tebipenem: Clinical Trials

2 trials of tebipenem, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow tebipenem: new trials by email Literature Review of tebipenem trials Research Report on tebipenem

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion - Urinary Tract Infection, Acute Pyelonephritis
Phase 3CompletedSpero Therapeutics16902023-12-212026-03-10
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
TBPM-PI-HBr, Ertapenem, Dummy Infusion - Complicated Urinary Tract Infection, Acute Pyelonephritis
Phase 3CompletedSpero Therapeutics13722019-06-032022-07-25

Conditions studied

Urinary Tract Infections (1)

Sponsors

Spero Therapeutics (2)

Countries

Bulgaria (2)  ·  Estonia (2)  ·  Georgia (2)  ·  Hungary (2)  ·  Latvia (2)  ·  Moldova (2)  ·  Poland (2)  ·  Romania (2)  ·  Serbia (2)  ·  Slovakia (2)  ·  South Africa (2)  ·  United States (2)  ·  Argentina (1)  ·  Bosnia and Herzegovina (1)  ·  Brazil (1)

Top investigators

David Hong, MD (1)  ·  David Melnick, MD (1)

Results publications

PMID 35388666

NIH funding

2018 (1), 2023 (1)